Group 1 - The company has conducted its 10th share buyback announcement in December, repurchasing 190,000 shares at a price of HKD 5.13 per share, totaling approximately HKD 1 million [1] - Cumulatively, the company has repurchased 3.34 million shares in December, with a total expenditure of around HKD 17 million, indicating strong confidence in its intrinsic value and long-term development [1] - The company has joined the Health Sustainable Development Working Committee under the Shanghai Cooperation Organization's economic platform, enhancing its role in international healthcare collaboration and innovation [1] Group 2 - The company has surpassed 3 million participants in the "Beijing Universal Health Insurance" program for 2026, showcasing its strong operational capabilities and market recognition in the health insurance sector [1] - The company has been elected as the vice-chair unit of the Smart Healthcare Working Committee of the China Internet Association, further solidifying its industry influence and technological leadership [1] - Financially, the company has shown positive signs of improvement, with revenue maintaining steady growth and nearing breakeven in its mid-term results for the 2026 fiscal year, attributed to improved gross margins and operational efficiency [1] Group 3 - Analysts suggest that the company's frequent buyback actions reflect a judgment of its current stock price being undervalued and indicate financial strength to support future strategic investments [2] - The continuous buybacks and recent developments send a positive signal to the market, aligning with the trend of deep integration of artificial intelligence and healthcare [2] - The company's established barriers through deep layout and innovative practices are making its long-term investment value increasingly clear as performance inflection points approach [2]

Group 1 - The company, Yidu Tech (02158), announced a share buyback plan on December 18, 2025, involving an expenditure of HKD 974,400 to repurchase 190,000 shares [1] - The repurchase price per share is set between HKD 5.10 and HKD 5.16 [1]

Core Viewpoint - The company demonstrates strong confidence in its intrinsic value and long-term development through frequent share buybacks, signaling positive financial health and operational capabilities [1][2]. Group 1: Share Buyback Activity - The company announced its 10th share buyback in December, repurchasing 190,000 shares at HKD 5.13 per share, totaling approximately HKD 1 million [1]. - Cumulatively, the company has repurchased 3.34 million shares in December, amounting to about HKD 17 million [1]. - Frequent and sustained buyback operations reflect the company's belief in its undervalued stock price and financial strength to support future strategic investments [2]. Group 2: Business Development and Industry Engagement - The company has joined the Health Sustainable Development Working Committee under the Shanghai Cooperation Organization's economic platform, enhancing its role in international healthcare collaboration [1]. - As the main operator of the "Beijing Universal Health Insurance" program, the company has surpassed 3 million insured participants, showcasing its strong operational capabilities in the public health insurance sector [1]. - The company has been elected as the deputy chairman unit of the Smart Healthcare Working Committee of the China Internet Association, further solidifying its industry influence and technological leadership [1]. Group 3: Financial Performance - The company reported steady revenue growth in its mid-term results for the fiscal year 2026, nearing breakeven [1]. - Significant improvement in key financial metrics is attributed to the continuous increase in gross margin of core business and enhanced operational efficiency [1]. - These financial indicators reflect the company's improved commercialization capabilities and substantial progress in operational quality [1].

Group 1 - The company, Yidu Tech (02158.HK), announced a share buyback on December 18, spending HKD 974,000 to repurchase 190,000 shares [1]

Core Viewpoint - The company, Yidu Tech (02158), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company will repurchase 190,000 shares at a total cost of HKD 974,400 [1] - The buyback price per share ranges from HKD 5.10 to HKD 5.16 [1] - The buyback is scheduled for December 18, 2025 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2025年12月18日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | | 已發行股份（不包括庫存股份）數 目 | ...

Group 1 - The company, Yidu Tech (02158), announced a share buyback plan to repurchase 400,000 shares at a cost of approximately HKD 1.9923 million on December 17, 2025 [1]

智通财经APP讯，医渡科技(02158)公布，2025年12月17日耗资约199.23万港元回购40万股股份。 ...

格隆汇12月17日丨医渡科技(02158.HK)公告，12月17日耗资199.2万港元回购40万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2025年12月17日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | | 已發行股份（不包括庫存股份）數 目 | ...